Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG43466

CD2AP Knockout Hela Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Uterus (cervix)

  • Disease:

    Adenocarcinoma

CD2AP Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited heterogeneous population designed for loss-of-function studies of the CD2AP adaptor protein. CD2AP links receptors such as CD2 and nephrin to the actin cytoskeleton and endocytic machinery, regulating processes critical for podocyte integrity and T-cell activation. This model enables investigation of CD2AP-dependent actin remodeling, endocytosis, and signaling pathways involving cortactin, PI3K, and c-Cbl in the HeLa cervical carcinoma background. Applications include mechanistic studies of podocyte slit diaphragm biology via ectopic nephrin expression, glomerular disease modeling, cancer cell motility assays, and endocytosis analysis.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HeLa

    Sex of Donor

    Female

    Age

    31 years

    Gene Name

    CD2AP

    Gene Identifier

    NCBI Gene ID 23607

    Morphology

    Epithelial-like

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    MEM (with NEAA)

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

CD2AP Knockout HeLa Polyclonal Cells are a heterogeneous CRISPR/Cas9-engineered population with disruption of the CD2AP gene, providing a loss-of-function model for adaptor protein studies. This polyclonal pool, derived from pooled editing events, enables investigation of CD2AP-dependent processes without clonal isolation. The gene disruption facilitates interrogation of actin cytoskeleton remodeling, endocytic trafficking, and receptor-mediated signaling, reflecting diverse editing outcomes that minimize clonal artifacts.

The host HeLa cell line originates from HPV-positive cervical adenocarcinoma and serves as a widely used model in cancer and cell biology due to robust growth and well-characterized signaling. HeLa cells retain actin dynamics, endocytosis, and adhesion pathways, making them suitable for dissecting CD2AP function, especially when podocyte factors like nephrin are ectopically expressed for slit diaphragm studies. Their transformed background also enables exploration of viral oncogenesis?Ccytoskeleton links.

CD2AP encodes a multidomain adaptor protein that physically bridges transmembrane receptors like CD2 and nephrin to the actin cytoskeleton and endocytic machinery. Mechanistically, CD2AP is recruited to activated receptor complexes, where it interacts with c-Cbl and cortactin to coordinate receptor internalization and actin polymerization. Its activity is regulated by Src family kinases such as Fyn and phosphoinositide signals, while downstream it scaffolds the PI3K p85 subunit and the AP-2 complex to propagate signals governing focal adhesion dynamics, lamellipodial protrusion, and vesicle trafficking. Disruption of CD2AP decouples these receptor-proximal events, impairing processes such as transferrin endocytosis and podocyte foot process maintenance.

In HeLa cells, CD2AP knockout allows dissection of actin?Ccortactin?CPI3K cascades critical for motility, invasion, and endosomal sorting??processes often deregulated in metastasis. Loss of CD2AP alters cortactin localization, reduces PI3K/Akt activation, and perturbs focal adhesions, enabling systematic analysis of cytoskeletal reorganization. Co-expression of nephrin can reconstitute podocyte-like signaling, facilitating studies of slit diaphragm pathology and focal segmental glomerulosclerosis.

Researchers can employ this knockout model in diverse assays: Western blotting to verify CD2AP ablation and monitor compensatory changes, immunofluorescence to visualize actin architecture and cortactin redistribution, and co-immunoprecipitation to map altered protein interactions. Functional endocytosis assays using transferrin uptake quantify trafficking defects, while migration and invasion assays reveal effects on cell motility. RT-qPCR can assess transcriptional responses in PI3K pathway components and nephrin-related genes. For further technical details or custom inquiries, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)